NFT ART
This is a page where you can find all NFT art created by Dina in one page. Click on the “Place a bid” button to visit the different websites to purchase the NFTs.
The Gantries, Long Island City
Minted on Jul3, 2021 on Foundation - 2.50 ETH
First NFT minted by Dina Brodsky. Ballpoint pen on paper as seen through the artist’s eyes. Drawn over a week, in the NYC Springtime.
Niki’s Dogs
Minted on OpenSea - 0.145 ETH
Farewell, Beech Tree
Minted on Rarible - Not for Sale
Bird By Bird
Minted on OpenSea
Bird By Bird. 36 Original Paintings by Dina Brodsky. 35 Bird Painting NFTs are "Nested" inside the King Penguins painting.
These are 36 unique 1/1 NFTs painted by Dina Brodsky. The owner may choose to keep 35 Nested in 1, or to separate them out.
The Bird By Bird Nested NFT is being sold to raise money for birdsforsofia.org -- a charity dedicated to saving the lives of babies with Spinal Muscular Atrophy.
Dina will also paint 1 more bird and send the physical artwork to the owner of this NFT (contact @DinaBrodsky on Instagram to receive this)
Birds for Sofia
Minted on OpenSea - 60 ETH
The mission of Birds For Sofia is to support children diagnosed with rare diseases from the underrepresented parts of the world. We help families to get access to gene therapy. We fast-forward the fundraising process before it is too late.
One of the major rare diseases we support is spinal muscular atrophy (SMA). It is a fatal genetic disease. SMA affects approximately one in every ten thousand babies born each year. Most of them do not live past two years of age.
One of the leading medicines to treat SMA, Zolgensma (by Novartis), is recognized by the Guinness Book of World Records as the most expensive medicine in the world ($2.1 million per one injection). Zolgensma replaces the function of the missing or non-working SMN1 gene with a new working copy of the human SMN1gene. In essence, it halts the disease at its root.
Zolgensma's accessibility is extremely low due to its astronomically high cost. Today, in many parts of the world, hundreds of SMA-afflicted children cannot receive the gene-based therapy they desperately need to survive.